Pregnancy Clinical Trial
Official title:
Exercise and Neurovascular Function During Pregnancy
Maintenance of a healthy pregnancy depends on an appropriate adaptation and responsiveness of
blood vessels, to ensure appropriate blood flow to the fetus during everyday stressors.
Previous work by the investigators has demonstrated that during pregnancy, the part of the
nervous system responsible for cardiovascular function (the sympathetic nervous system) is
hyperactive. The investigators also know that in women who develop high blood pressure during
pregnancy that sympathetic nervous system activity is even higher. Yet, very little is known
about why this occurs and how this might be affected.
Pregnant women are encouraged to be active, yet, less than 15% of women perform sufficient
exercise to meet current guidelines. This is important because hyperactivity of the
sympathetic nervous system is observed in other inactive populations and has been linked to
adverse cardiovascular health outcomes including hypertension, atherosclerosis, heart attack,
and stroke. Indeed, in 2011, the American Heart Association stated that inactivity was a risk
factor as potent as cigarette smoking for the development of future cardiovascular disease in
women.
The investigators' work and others have demonstrated that exercise during pregnancy is
beneficial for both the mom and baby; however, the effect of prenatal exercise on
neurovascular function is not known. If exercise is effective in controlling the increase in
sympathetic activity that occurs during pregnancy, or its effects on the cardiovascular
system, this may help prevent the development of high blood pressure or other cardiovascular
problems during pregnancy.
The objectives of this study are to: 1) examine the impact of exercise on sympathetic and
vascular function during pregnancy; 2) examine the role of endothelial function on the
vascular effects of exercise during pregnancy.
Study design:
100 women (>18yrs) will be recruited in the first or second trimester (<20 wks). Women with
multiple pregnancies will be excluded. Eligible women will be randomized between an aerobic
exercise intervention (EXER) or no intervention (CTRL).
Initial testing will take place between 16-20 weeks of pregnancy. Following initial baseline
testing, women will be randomly assigned to an exercise intervention or no intervention.
Women will receive an opaque sequentially numbered envelop with their allocation. Allocation
will be determined using a randomly generated allocation sequence by an individual not
associated with the research study. The intervention will consist of aerobic exercise
equivalent to 50-70% of heart rate reserve, 3-4 times per week until the end of the study
(34-36 weeks). For initial baseline testing (16-20 weeks) and at the end of the intervention
(34-36 weeks), participants will visit the laboratory twice
On Day 1, participants will complete a peak exercise test on the treadmill or bike to
volitional fatigue to measures fitness and cardiovascular/cerebrovascular responses to
exercise.
On Day 2 Participants will arrive fasted (12 hrs) and blood samples will be collected.
Anthropometrics, personal/familial history of hypertension and pregnancy complications will
be recorded. Following a standardized breakfast, participants will undergo an assessment of
reflex neurovascular control including a cold pressor test, flow mediated dilation and end
expiratory voluntary breath hold. Muscle sympathetic nerve activity, ultrasound (blood flow
and diameter of brachial, femoral and carotid arteries), blood pressure, heart rate and
respiratory variables will be measured.
OUTCOME/IMPACT
Pregnancy is a stress-test for life; with women who develop complications during pregnancy
having a higher risk for cardiovascular disease later in life. Exercise is well known to
prevent cardiovascular disease through improvements in endothelial function and the
sympathetic nervous system. Whether this improvements is also seen in pregnancy remains to be
seen.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02523755 -
Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia
|
Phase 4 |